Trial Outcomes & Findings for Inhaled Nitrous Oxide and Labor Analgesia (NCT NCT01738672)

NCT ID: NCT01738672

Last Updated: 2017-11-21

Results Overview

Participant reported pain score, using a numerical rating scale (NRS) ranging from no pain (0) to severe pain (10).

Recruitment status

TERMINATED

Study phase

PHASE2

Target enrollment

16 participants

Primary outcome timeframe

At baseline, and at 1 hour after initiation of nitrous oxide

Results posted on

2017-11-21

Participant Flow

Participant milestones

Participant milestones
Measure
Nitrous Oxide
Parturients who request labor analgesia will be offered inhaled nitrous oxide for labor analgesia. Inhaled nitrous oxide: Administration of nitrous oxide for labor analgesia
Overall Study
STARTED
16
Overall Study
COMPLETED
11
Overall Study
NOT COMPLETED
5

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Inhaled Nitrous Oxide and Labor Analgesia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Nitrous Oxide
n=16 Participants
Parturients who request labor analgesia will be offered inhaled nitrous oxide for labor analgesia. Inhaled nitrous oxide: Administration of nitrous oxide for labor analgesia
Age, Continuous
30 years
n=5 Participants
Sex: Female, Male
Female
16 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: At baseline, and at 1 hour after initiation of nitrous oxide

Population: Data are included for all participants from which they were collected.

Participant reported pain score, using a numerical rating scale (NRS) ranging from no pain (0) to severe pain (10).

Outcome measures

Outcome measures
Measure
Nitrous Oxide
n=16 Participants
Parturients who request labor analgesia will be offered inhaled nitrous oxide for labor analgesia. Inhaled nitrous oxide: Administration of nitrous oxide for labor analgesia
Labor Pain
Baseline
8.88 units on a scale
Standard Deviation 0.97
Labor Pain
1 hour after initiation of nitrous oxide
8.18 units on a scale
Standard Deviation 1.72

OTHER_PRE_SPECIFIED outcome

Timeframe: At baseline, and at 1 hour after initiation of nitrous oxide

Population: Data are included for all participants from which they were collected.

Participant reported anxiety score, using a numerical rating scale (NRS) ranging from no anxiety (0) to severe anxiety (10).

Outcome measures

Outcome measures
Measure
Nitrous Oxide
n=15 Participants
Parturients who request labor analgesia will be offered inhaled nitrous oxide for labor analgesia. Inhaled nitrous oxide: Administration of nitrous oxide for labor analgesia
Anxiety
Baseline
2.50 units on a scale
Standard Deviation 3.54
Anxiety
1 hour after initiation of nitrous oxide
2.00 units on a scale
Standard Deviation 3.35

OTHER_PRE_SPECIFIED outcome

Timeframe: At baseline, and at 1 hour after initiation of nitrous oxide

Population: Data are included for all participants from which they were collected.

Participant reported nausea score, using a numerical rating scale (NRS) ranging from no nausea (0) to severe nausea (10).

Outcome measures

Outcome measures
Measure
Nitrous Oxide
n=16 Participants
Parturients who request labor analgesia will be offered inhaled nitrous oxide for labor analgesia. Inhaled nitrous oxide: Administration of nitrous oxide for labor analgesia
Nausea
Baseline
0.25 units on a scale
Standard Deviation 0.58
Nausea
1 hour after initiation of nitrous oxide
0.46 units on a scale
Standard Deviation 1.03

OTHER_PRE_SPECIFIED outcome

Timeframe: During administration of nitrous oxide

Population: Data are included for all participants from which they were collected.

Participant reported emesis (yes or no).

Outcome measures

Outcome measures
Measure
Nitrous Oxide
n=16 Participants
Parturients who request labor analgesia will be offered inhaled nitrous oxide for labor analgesia. Inhaled nitrous oxide: Administration of nitrous oxide for labor analgesia
Emesis
1 participants experiencing emesis

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 hours after delivery

Population: Data are included for all participants from which they were collected.

Participant reported score of satisfaction with nitrous oxide for labor analgesia, using a numerical rating scale (NRS) ranging from completely dissatisfied (0) to completely satisfied (100).

Outcome measures

Outcome measures
Measure
Nitrous Oxide
n=3 Participants
Parturients who request labor analgesia will be offered inhaled nitrous oxide for labor analgesia. Inhaled nitrous oxide: Administration of nitrous oxide for labor analgesia
Participant Satisfaction
90 units on a scale
Interval 85.0 to 100.0

OTHER_PRE_SPECIFIED outcome

Timeframe: Initiation of nitrous oxide to completion of delivery.

Population: Data are included for all participants from which they were collected.

Participants crossing over from nitrous oxide to epidural.

Outcome measures

Outcome measures
Measure
Nitrous Oxide
n=15 Participants
Parturients who request labor analgesia will be offered inhaled nitrous oxide for labor analgesia. Inhaled nitrous oxide: Administration of nitrous oxide for labor analgesia
Crossover To Epidural
8 participants

Adverse Events

Nitrous Oxide

Serious events: 0 serious events
Other events: 16 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Nitrous Oxide
n=16 participants at risk
Parturients who request labor analgesia will be offered inhaled nitrous oxide for labor analgesia. Inhaled nitrous oxide: Administration of nitrous oxide for labor analgesia
General disorders
Pain
100.0%
16/16
Psychiatric disorders
Anxiety
43.8%
7/16
Gastrointestinal disorders
Nausea
18.8%
3/16
Gastrointestinal disorders
Vomiting
6.2%
1/16
Cardiac disorders
Sinus Bradycardia
6.2%
1/16
Cardiac disorders
Sinus Tachycardia
18.8%
3/16
Vascular disorders
Hypertension
12.5%
2/16
Vascular disorders
Hypotension
18.8%
3/16

Additional Information

Ya'aqov Abrams, MD

University of Pittsburgh

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place